Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.1.1 extracted from

  • Mergenthaler, P.; Kahl, A.; Kamitz, A.; van Laak, V.; Stohlmann, K.; Thomsen, S.; Klawitter, H.; Przesdzing, I.; Neeb, L.; Freyer, D.; Priller, J.; Collins, T.J.; Megow, D.; Dirnagl, U.; Andrews, D.W.; Meisel, A.
    Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state (2012), Proc. Natl. Acad. Sci. USA, 109, 1518-1523.
    View publication on PubMedView publication on EuropePMC

Organism

Organism UniProt Comment Textmining
Rattus norvegicus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
cerebral cortex
-
Rattus norvegicus
-

Synonyms

Synonyms Comment Organism
hexokinase II
-
Rattus norvegicus
HKII
-
Rattus norvegicus

General Information

General Information Comment Organism
malfunction hypoxia-inducible factor (HIF)-1-regulated glycolytic enzyme hexokinase II (HKII) acts as a molecular switch that determines cellular fate by regulating both cytoprotection and induction of apoptosis based on the metabolic state. Together with phosphoprotein enriched in astrocytes (PEA15), HKII inhibits apoptosis after hypoxia. In contrast, HKII accelerates apoptosis in the absence of PEA15 and under glucose deprivation Rattus norvegicus